Astellas tests gamification ideas with Japanese universitiesAstellas has teamed up with Tokyo University of the Arts and Yokohama City University to create and commercialise Share XAstellas tests gamification ideas with Japanese universitieshttps://pharmaphorum.com/news/astellas-tests-gamification-ideas-with-japanese-universities/
AbbVie/Janssen win EU approval for two new Imbruvica usesEuropean regulators have approved AbbVie and Janssen’s Imbruvica (ibrutinib) in two expanded uses that broaden the use of Share XAbbVie/Janssen win EU approval for two new Imbruvica useshttps://pharmaphorum.com/news/eu-regulators-approve-two-new-uses-for-janssens-imbruvica/
Pharming buys rare disease drug from Novartis for $20mPharming has bought a late-stage pipeline drug aimed at a rare disease of the immune system from Novartis Share XPharming buys rare disease drug from Novartis for $20mhttps://pharmaphorum.com/news/pharming-buys-rare-disease-drug-from-novartis-for-20m/
NHS patients to receive digital diabetes prevention supportThousands of patients at risk of type 2 diabetes are to receive digital support to help prevent them Share XNHS patients to receive digital diabetes prevention supporthttps://pharmaphorum.com/news/nhs-patients-to-receive-digital-diabetes-support/
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatmentAstraZeneca and MSD’s Lynparza has scored its second Phase 3 win in the space of a week, this Share XAZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatmenthttps://pharmaphorum.com/news/az-msd-parp-inhibitor-ovarian-cancer/
McCann Health promotes Hilary Gentile to global chief strategy officerMcCann Health has promoted Hilary Gentile to the newly created position of global chief strategy officer. Hilary has Share XMcCann Health promotes Hilary Gentile to global chief strategy officerhttps://pharmaphorum.com/news/mccann-health-promotes-hilary-gentile-to-global-chief-strategy-officer/
First effective Ebola treatment a step closer after breakthrough trialClinical trials of four experimental treatments for Ebola in the Congo have been halted early after two of Share XFirst effective Ebola treatment a step closer after breakthrough trialhttps://pharmaphorum.com/news/ebola-virus-clinical-trial-breakthrough/
LIVI expands reach for its NHS GP consultation mobile appDigital healthcare firm LIVI has signed new agreements with the NHS that will open up access to its Share XLIVI expands reach for its NHS GP consultation mobile apphttps://pharmaphorum.com/news/nhs-gp-consultation-app-expanded/
GSK announces US leadership changesGlaxoSmithKline has poached Merck KGaA’s Maya Martinez-Davis to head up its US Pharmaceuticals division as it announces current Share XGSK announces US leadership changeshttps://pharmaphorum.com/news/gsk-announces-us-leadership-changes/
